Skip to main content
. 2023 Jan 5;11(1):e02376-22. doi: 10.1128/spectrum.02376-22

FIG 6.

FIG 6

Correlation between the production of anti-S1/S2 IgG antibodies and the neutralizing capacity of the antibodies directed at the RBD in participants with COVID-19 prior to vaccination. (A) BNT162b2; (B) AZD1222; (C) Convidecia; (D) Sputnik V; (E) CoronaVac.